Inhibitors of 4-HNE-metabolizing enzymes including GSTA4 [14], AKR [38,40,41], ALDH [42,43,44] or Rlip [18,19,20,21,22,23,45] are selectively toxic to cancer cells. This evidence concerns the gene RALBP1 and cancer.